| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-912
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64 |
| filingDate |
2013-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22cbce8c477f3d5802189fcb11ba68d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c05636a0a90c6f6d04fc51029072241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c7a16f619968af7c285c6eadc4e01e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_556748843d26b1f6693353a0f9e8d7a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b0dec2aef32c68121d2d810e193acd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d63b967ad9b0da1f01aeeb1adddeb357 |
| publicationDate |
2014-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8853251-B2 |
| titleOfInvention |
Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases |
| abstract |
The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555021-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9193690-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015080445-A1 |
| priorityDate |
2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |